Hem › Akut bifentypisk leukemi › Pennsylvania › Pittsburgh
Kliniska studier för Akut bifentypisk leukemi i Pittsburgh, PA
3 studier för Akut bifentypisk leukemi söker deltagare vid platser i och runt Pittsburgh (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
RekryterarFas 2
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
RekryterarFas 3
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekryterarFas 1/2
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Akut bifentypisk leukemi-studier i andra städer
- Seattle, WA15 studier
- Houston, TX11 studier
- New York City, NY10 studier
- Atlanta, GA9 studier
- Durham, NC8 studier
- Memphis, TN7 studier
- Chicago, IL7 studier
- Charlotte, NC6 studier
- Aurora, CO6 studier
- Baldwin Park, CA6 studier
- Portland, OR6 studier
- Los Angeles, CA6 studier
Andra studier i Pittsburgh
- Icke-småcellig lungcancer48 studier
- Cancer (alla typer)41 studier
- Bröstcancer39 studier
- Kolorektal cancer32 studier
- Metastaserande cancer31 studier
- Melanom31 studier
- Äggstockscancer30 studier
- Endometriecancer23 studier
- Lungcancer23 studier
- Prostatacancer23 studier
- Stroke22 studier
- Plattenepitelcancer i huvud och hals22 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.